| Literature DB >> 21253533 |
K Shiva Prasad1, L Shiva Kumar, Melvin Prasad, Hosakere D Revanasiddappa.
Abstract
Four organotin(IV) compEntities:
Year: 2010 PMID: 21253533 PMCID: PMC3021846 DOI: 10.1155/2010/854514
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Scheme 1Synthetic route of the ligands.
Analytical data and some physical properties of the Schiff base ligands and their organotin(IV) complexes.
| Compound | Mol. formula | Yield% |
| Molar conductivity Scm2 mol−1 | ||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| C | H | S | O | N | ||||
| L1 | C15H10N2O3 | 84 | 67.41 (67.60) | 3.72 (3.75) | — | 17.88 (18.02) | 10.32 (10.51) | — |
|
| C17H15N2O3Sn | 67 | 49.09 (49.32) | 3.51 (3.65) | — | 11.42 (11.59) | 6.66 (6.76) | 9.20 |
|
| C29H23N4O3Sn | 73 | 58.52 (58.61) | 3.78 (3.90) | — | 7.82 (8.02) | 9.31 (9.42) | 4.25 |
| L2 | C18H16N4O4S | 82 | 55.91 (56.24) | 4.01 (4.20) | 8.19 (8.34) | 16.3 (16.65) | 14.41 (1457) | — |
|
| C38H34N8O8S2Sn | 57 | 49.86 (49.95) | 3.61 (3.75) | 6.91 (7.01) | 13.87 (14.01) | 12.09 (12.26) | 5.62 |
|
| C32H30N6O4SSn | 62 | 52.11 (53.87) | 4.91 (4.23) | 4.28 (4.49) | 8.66 (8.97) | 11.61 (11.78) | 8.93 |
Infrared spectral data of the ligands and their organotin(IV) complexes.
|
| ||||||
|---|---|---|---|---|---|---|
| compound |
|
|
|
|
|
|
| L1 | 1768 and 1725 | 3384 | 1618 | — | — | — |
|
| 1676 | — | — | 512 | 384 | — |
|
| 1650 and 1725 | — | 1617 | 516 | 417 | — |
| L2 | — | 3423 | 1652 | — | — | 941 |
|
| — | — | — | 480 and 461 | 403 | 891 |
|
| — | 3423 | 1658 | 415 | — | 941 |
1H-NMR data of the ligands and organotin(IV) complexes.
| compound | HC=N | –OH | Ar–H | –NH | Sn–CH3 | O–CH3 |
|---|---|---|---|---|---|---|
| L1 | 9.45 | 10.67 | 6.92–7.91 | — | — | — |
|
| 9.46 | 10.63 | 6.90–7.88 | — | — | — |
|
| 9.46 | 10.65 | 6.92–7.94 | — | — | — |
| L2 | 9.77 | 10.26 | 6.01–7.95 | 11.24 | — | 3.84 |
|
| 9.77 | 10.28 | 6.01–7.93 | 11.30 | 1.03 | 3.84 |
|
| 9.75 | 10.26 | 6.01–7.95 | — | 1.03 | 3.82 |
Figure 1(a) Thermogravimetric (TGA) curve of organotin(IV) complexes (1–4) and (b) DSC curve of ligand (L1) and complexes (1 and 2).
Figure 2Structures of ligands and organotin(IV) complexes [M=Sn(IV)].
Antimicrobial activity of Schiff bases and their corresponding organotin(IV) complexes.
| Compound | Antibacterial activity | Antifungal activity | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Zone of inhibition (in mm)* | |||||||||
|
|
|
|
|
|
|
|
|
| |
| L1 | 05 | 04 | 06 | 08 | 04 | 07 | 05 | 04 | 08 |
|
| 20 | 23 | 21 | 27 | 22 | 24 | 21 | 19 | 22 |
|
| 17 | 24 | 19 | 23 | 19 | 22 | 17 | 18 | 21 |
| L2 | 09 | 06 | 05 | 11 | 04 | 09 | 08 | 05 | 10 |
|
| 19 | 11 | 20 | 26 | 21 | 23 | 20 | 21 | 23 |
|
| 14 | 12 | 17 | 21 | 15 | 21 | 15 | 17 | 19 |
| Chloramphenicol | 29 | 26 | 25 | 32 | 35 | — | — | — | — |
| Griseofulvin | — | — | — | — | — | 27 | 23 | 26 | 25 |
*Average of three replicates.
Figure 4Absorption spectra of (a) complex 1 (5.0 × 10−5 M) and (b) complex 3 (5.0 × 10−5 M), in Tris-HCl buffer upon addition of DNA = 0.5 μM, 0–100 μL. Arrow shows the absorbance changing upon increasing the concentration of DNA.
Figure 5The plot of [DNA]/(ε − ε ) versus [DNA] for the titration of DNA with the complexes (a) 1 and (b) 3.
Figure 6Effect of increasing amounts of complexes (1 and 3) and ligands on the relative viscosity of CT-DNA at 25 ± 0.1°C.
Figure 3Cleavage of supercoiled pUC19 DNA (0.5 μg) by the ligands and complexes (a) 1 and (b) 3 in a buffer containing 50 mM Tris-HCl at 37°C (30 min). lane M: marker; lane 1: DNA control; lane 2: L1 (10−3 M) + DNA; lane 3: DNA + H2O2; lane 4: L2 + DNA + H2O2; lane 5: complex (10−3 M) + DNA; lane 6: complex + DNA + H2O2.